Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 768-781
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.768
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.768
Figure 4 Positional differences in resectable pancreatic cancer between simulation and during treatment in three directions.
Error bars indicates the 95% confidence intervals. Positive values of marker displacement indicate that the position of the marker during treatment moves to the anterior, inferior, or left directions from the simulation. Positional differences in resectable pancreatic cancer between simulation and treatment were marked, particularly in the superior-inferior direction. Yellow area between orange arrows indicate planning target volume margin. A–P: Antero-posterior; S–I: Superior-inferior; L–R: Left–right; PTV: Planning target volume.
- Citation: Ashida R, Fukutake N, Takada R, Ioka T, Ohkawa K, Katayama K, Akita H, Takahashi H, Ohira S, Teshima T. Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer. World J Gastrointest Oncol 2020; 12(7): 768-781
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/768.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.768